Clinical trial
Transvenous Nerve Stimulation Study (Janus Study)
NCT03985527 is registered in ClinicalTrials.gov with Respicardia, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Transvenous Nerve Stimulation Study (Janus Study)
- Lead sponsor
- Respicardia, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 9, 2020
- Completion date
- December 12, 2025
- Enrollment
- 29 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.